A Novel Partial PPARĪ³ Agonist Has Weaker Lipogenic Effect in Adipocytes and Stimulates GLUT4 Translocation in Skeletal Muscle Cells via AMPK-Dependent Signaling.
Sign Up to like & getrecommendations! Published in 2021 at "Pharmacology"
DOI: 10.1159/000519331
Abstract: INTRODUCTION Peroxisome proliferator-activated receptor gamma (PPARĪ³) agonists are highly effective in treating insulin resistance. However, associated side effects such as weight gain due to increase in adipogenesis and lipogenesis hinder their clinical use. The aim… read more here.
Keywords: ppar; glut4 translocation; novel partial; effect ... See more keywords